SCHEMBL6336476

SCHEMBL6336476

O=C(N[C@H]1CCCC[C@@H]1O)c1cn(-c2ccc(F)cc2)c(-c2ccc(Cl)cc2Cl)n1

nearest known ligand 0.89

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 20/20 0.89
CNR2 P34972 6/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6336481 1.00 CNR1 (0.89) CNR1CNR2
SCHEMBL6336478 1.00 CNR1 (0.89) CNR1CNR2
SCHEMBL6334949 0.94 CNR1 (1.00) CNR1CNR2
SCHEMBL6340565 0.94 CNR1 (1.00) CNR1CNR2
SCHEMBL6340563 0.94 CNR1 (1.00) CNR1CNR2
SCHEMBL6334670 0.93 CNR1 (0.96) CNR1CNR2
SCHEMBL6343796 0.93 CNR1 (0.96) CNR1CNR2
SCHEMBL6334654 0.89 CNR1 (0.85) CNR1CNR2
SCHEMBL6334656 0.89 CNR1 (0.85) CNR1CNR2
SCHEMBL6334651 0.89 CNR1 (0.85) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6960601-B2 Preparation and use of imidazole derivatives for treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2005-11-01 US disclosed